中华内分泌外科杂志
中華內分泌外科雜誌
중화내분비외과잡지
CHINESE JOURNAL OF ENDOCRINE SURGERY
2009年
2期
95-96,119
,共3页
125碘%胰腺癌%近距离肿瘤放射治疗%临床分期
125碘%胰腺癌%近距離腫瘤放射治療%臨床分期
125전%이선암%근거리종류방사치료%림상분기
125Ⅰodine%Pancreatic cancer%Brachytherapy%Clinical staging
目的 明确125Ⅰ放射性粒子肿瘤内永久植入治疗Ⅳ期胰腺癌患者的意义.方法 回顾分析在CT、超声引导下125Ⅰ放射性粒子治疗18例Ⅳ期胰腺癌临床资料,观察疼痛缓解情况及平均生存期,并与国内大宗统计数据结果比较.结果 疼痛缓解率70.6%(12/17),开始缓解平均时间2.9 d;术后生存期2.5~11.5个月,平均5.2个月,较中国抗癌协会胰腺癌专业委员会统计的Ⅳ期胰腺癌患者生存期(3.0个月)明显延长.结论 125Ⅰ放射性粒子治疗可有效提高Ⅳ期胰腺癌患者的生活和生存质量.
目的 明確125Ⅰ放射性粒子腫瘤內永久植入治療Ⅳ期胰腺癌患者的意義.方法 迴顧分析在CT、超聲引導下125Ⅰ放射性粒子治療18例Ⅳ期胰腺癌臨床資料,觀察疼痛緩解情況及平均生存期,併與國內大宗統計數據結果比較.結果 疼痛緩解率70.6%(12/17),開始緩解平均時間2.9 d;術後生存期2.5~11.5箇月,平均5.2箇月,較中國抗癌協會胰腺癌專業委員會統計的Ⅳ期胰腺癌患者生存期(3.0箇月)明顯延長.結論 125Ⅰ放射性粒子治療可有效提高Ⅳ期胰腺癌患者的生活和生存質量.
목적 명학125Ⅰ방사성입자종류내영구식입치료Ⅳ기이선암환자적의의.방법 회고분석재CT、초성인도하125Ⅰ방사성입자치료18례Ⅳ기이선암림상자료,관찰동통완해정황급평균생존기,병여국내대종통계수거결과비교.결과 동통완해솔70.6%(12/17),개시완해평균시간2.9 d;술후생존기2.5~11.5개월,평균5.2개월,교중국항암협회이선암전업위원회통계적Ⅳ기이선암환자생존기(3.0개월)명현연장.결론 125Ⅰ방사성입자치료가유효제고Ⅳ기이선암환자적생활화생존질량.
Objective Subjective to identify the significance of interstitial implantation of 125Ⅰ seeds in stage Ⅳ pancreatic cancer patients.Methods Retrospectively analysis the clinical datum of 18 cases of stage Ⅳ pancreatic cancer patients treated with the 125Ⅰ seeds implantation, and observe the pain relief rate and the average survival period, then compare with the bulk of domestic statistical datum.Results The rate of easement of pain was 70.6% (12/17) , and the mean time begin to relieve was 2.9 days .The life span after the operation was be-tween 2.5 and 11.5 months , and 5.2 months on average,which is longer conspicuously than the statistics of the past.Conclusions The methods of interstitial implantation of 125Ⅰ seeds can upgrade the quality of the life and living efficiently of stage Ⅳ pancreatic cancer patients.